[HTML][HTML] Safety monitoring of the janssen (johnson & johnson) COVID-19 vaccine—United States, march–april 2021
DK Shay - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
DK Shay
MMWR. Morbidity and mortality weekly report, 2021•cdc.govSafety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States,
March–April 2021 | MMWR Skip directly to site content Skip directly to search Español | Other
Languages Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives,
Protecting People Search Submit Morbidity and Mortality Weekly Report (MMWR) Safety
Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States,
March–April 2021 Weekly / May 7, 2021 / 70(18);680–684 Related Pages On April 30, 2021 …
March–April 2021 | MMWR Skip directly to site content Skip directly to search Español | Other
Languages Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives,
Protecting People Search Submit Morbidity and Mortality Weekly Report (MMWR) Safety
Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States,
March–April 2021 Weekly / May 7, 2021 / 70(18);680–684 Related Pages On April 30, 2021 …
An Emergency Use Authorization of the Janssen COVID-19 vaccine was granted February 27, 2021. Use was paused during April 12–23, 2021, after detection of six cases of cerebral venous sinus thrombosis (CVST).
cdc.gov